台股 » 個股 » 國光生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國光生

(4142)
可現股當沖
  • 股價
    28.55
  • 漲跌
    ▲1.20
  • 漲幅
    +4.39%
  • 成交量
    5,562
  • 產業
    上市 生技醫療類股
  • 635人加入追蹤

    立即追蹤

  • 本地時間:14:30

     
國光生 (4142)籌碼相關-凱基-七賢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

凱基-七賢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/03/18020.0000.0019.9506780.00%
2019/03/15020.3000.0019.9506830.00%
2019/03/14021.7500.0019.9506890.00%
2019/03/13020.3000.0020.2007070.00%
2019/03/12021.9000.0020.1507250.00%
2019/03/11021.50220.2020.20-2739-0.27%
2019/03/08020.0000.0019.9507750.00%
2019/03/07019.9500.0019.9508770.00%
2019/03/06021.9000.0020.0009190.00%
2019/02/1500.00520.5520.20-51,003-0.50%
2019/01/2100.00820.0520.05-81,401-0.57%
2019/01/0800.00120.8020.60-12,024-0.05%
2019/01/0200.00220.3020.00-22,630-0.08%
2018/12/28220.0500.0020.3022,8060.07%
2018/12/27120.10520.1520.05-42,916-0.14%
2018/12/25520.2500.0020.0553,2470.15%
2018/12/20320.9500.0020.6533,7210.08%
2018/12/191521.2400.0021.20153,7120.40%
2018/12/17521.66322.4022.2023,7100.05%
2018/12/1400.00221.2521.20-23,697-0.05%
2018/12/13221.5500.0021.5523,7170.05%
2018/11/28221.0000.0021.0023,7200.05%
2018/11/2700.00621.4020.90-63,710-0.16%
2018/11/23620.5900.0020.4063,6830.16%
2018/11/20621.5000.0021.4563,6380.16%
2018/11/1300.00121.9522.10-13,566-0.03%
2018/11/12821.922021.7021.60-123,530-0.34%
2018/11/092222.2700.0022.35223,4820.63%
2018/11/06121.1500.0020.3013,3940.03%
2018/11/02521.2500.0021.0053,3710.15%
2018/10/25121.8000.0021.3013,1360.03%
2018/10/2400.001023.4023.00-103,087-0.32%
2018/10/2300.00224.2024.05-23,036-0.07%
2018/10/22324.6500.0024.5533,0100.10%
2018/10/181025.64625.7725.7543,0130.13%
2018/10/17124.5000.0024.9512,9810.03%
2018/10/16524.0700.0024.0552,9900.17%
2018/10/1200.00425.7025.30-42,825-0.14%
2018/10/11423.5500.0025.0042,6520.15%
2018/10/09325.53125.7526.1522,4680.08%
2018/10/031124.45124.6024.90101,8940.53%
2018/10/0200.00322.7024.50-31,635-0.18%
2018/10/01221.93322.2022.95-11,382-0.07%
2018/09/2600.00119.7019.65-11,153-0.09%
2018/09/1800.00120.5520.60-11,089-0.09%
2018/09/1700.00119.1519.05-11,014-0.10%
2018/09/13120.7500.0020.5019610.10%
2018/08/28118.3000.0018.3018060.12%
2018/08/17218.3500.0018.2028210.24%
2018/08/1500.00318.3018.20-3842-0.36%
2018/08/1400.00318.5518.65-3843-0.36%
2018/08/13319.2500.0018.8038330.36%
2018/08/02119.3500.0019.6017630.13%
2018/08/01119.5000.0019.6517590.13%
2018/07/3000.00419.2519.25-4732-0.55%
2018/07/27119.20219.2019.20-1721-0.14%
2018/07/25320.40120.5020.3526600.30%
2018/07/24920.23120.2020.0085871.36%
2018/06/20118.6500.0018.6516990.14%
2018/06/0700.00119.5019.35-1703-0.14%
2018/05/2400.00119.3019.25-1779-0.13%
2018/05/2300.00118.9018.75-1766-0.13%
2018/05/11118.3000.0018.2517980.13%
2018/04/27119.0000.0019.0017920.13%
2018/04/23119.6000.0019.6018070.12%
2018/04/13119.2000.0019.1519370.11%
2018/04/02119.1500.0019.2017600.13%
2018/03/1200.00119.6519.90-1744-0.13%
2018/03/0700.00319.9019.90-3709-0.42%
2018/03/0600.00219.7519.95-2703-0.28%
2018/02/12117.8500.0017.9517470.13%
2018/02/06118.5500.0018.3017410.13%
2018/01/3000.00220.3520.15-2745-0.27%
2018/01/1600.00121.5021.10-1905-0.11%
國光生去年營運轉虧 今年拚重回成長軌道Anue鉅亨-2024/03/13
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
國光生 相關文章